Sagimet Biosciences Announces Publication of Results from Phase 2b FASCINATE-2 …

SAN MATEO, Calif., Oct. 11, 2024 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company …

Continue

Do you trust this headline?

Based on recent headline ratings, 82% of this readership currently trusts the local media, which has an average score of 83% regionally and is currently trending positivenegative.

82%

Media Trust Score82%

Read All

In

News